Anixa biosciences stock.

SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...Anixa Biosciences, Inc. 3150 Almaden Expressway. Suite 250 San Jose, CA 95118 408-708-9808 [email protected] Detailed balance sheet for Anixa Biosciences, Inc. (ANIX), including cash, debt, assets, liabilities, and book value. ... Stock Analysis Pro. Watchlist. Collapse. Anixa Biosciences, Inc. (ANIX) NASDAQ: ANIX · IEX Real-Time Price · USD. Add to Watchlist 3.27-0.07 (-2.10%)Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.Detailed statistics for Anixa Biosciences, Inc. (ANIX) stock, including valuation metrics, financial numbers, share information and more.

Stock analysis for Anixa Biosciences Inc (ANIX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. ANIX Stock Performance. USD USD; Previous close: 3.34: 3.34: Day range: 3.25 - 3.433.25 - 3.43Year range: 2 - 62 - 6Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

Discover historical prices for ANIX stock on Yahoo Finance. View daily, weekly or monthly format back to when Anixa Biosciences, Inc. stock was issued.SAN JOSE, Calif., Nov. 8, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...

13 Mar 2023 ... About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's ...Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Canadian Intellectual ...SAN JOSE, Calif., Aug. 7, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...Zacks Equity Research. Anixa Biosciences, Inc. ANIX was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares ...

About Anixa Biosciences, Inc. Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a …

Find real-time ANIX - Anixa Biosciences Inc stock quotes, company profile, news and forecasts from CNN Business. ... Anixa Biosciences Inc (NASDAQ:ANIX) 3.34. Delayed Data. As of 3:59pm ET

Anixa Biosciences, Inc. is a biotechnology company, which engages in developing therapies and vaccines that are focused on critical unmet needs in oncology ...During the same time frame, the estimate for Anixa Biosciences’ 2024 loss per share has remained constant at 37 cents. Year to date, shares of ANIX have lost 32.2%.Dec 1, 2023 · Anixa Biosciences Stock Price, News & Analysis (NASDAQ:ANIX) $3.27 -0.07 (-2.10%) (As of 12/1/2023 ET) Compare Today's Range $3.25 $3.43 50-Day Range $2.85 $3.64 52-Week Range $2.75 $6.45 Volume 45,375 shs Average Volume 70,005 shs Market Capitalization $101.60 million P/E Ratio N/A Dividend Yield N/A Price Target $10.50 Chardan Capital analyst Matthew Barcus maintained a Buy rating on Anixa Biosciences (ANIX – Research Report) today and set a price target of $9.00.The company’s shares opened today at $4.12 ...Dec 1, 2023 · Anixa Biosciences Stock Price, News & Analysis (NASDAQ:ANIX) $3.27 -0.07 (-2.10%) (As of 12/1/2023 ET) Compare Today's Range $3.25 $3.43 50-Day Range $2.85 $3.64 52-Week Range $2.75 $6.45 Volume 45,375 shs Average Volume 70,005 shs Market Capitalization $101.60 million P/E Ratio N/A Dividend Yield N/A Price Target $10.50 Anixa Biosciences (ANIX) In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Anixa Biosciences, with a price target of $12.00 . The company’s shares closed last ...SAN JOSE, Calif., Nov. 27, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the …

Valuation metrics show that ANIXA BIOSCIENCES INC may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial ...In the previous week, Anixa Biosciences had 3 more articles in the media than Cue Biopharma. MarketBeat recorded 4 mentions for Anixa Biosciences and 1 mentions for Cue Biopharma. Anixa Biosciences' average media sentiment score of 1.87 beat Cue Biopharma's score of 0.18 indicating that Cue Biopharma is being referred to more favorably in the ...Anixa Biosciences, Inc. company earnings calendar and analyst expectations - Upcoming and past events | BOERSE MUENCHEN: CY71 | BOERSE MUENCHENAnixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit. IMPACT. SENTIMENT. 08/10/2023 09:30 AM. ANIX : Nasdaq.Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Canadian Intellectual ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in partnership with Moffitt ...Looking more specifically, ANIXA BIOSCIENCES INC belongs to the Medical - Biomedical and Genetics industry, which includes 554 individual stocks and currently sits at #78 in the Zacks Industry Rank.

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.Apr 18, 2023 · In a report released today, Matthew Barcus from Chardan Capital reiterated a Buy rating on Anixa Biosciences (ANIX – Research Report), with a price target of $9.00.The company’s shares closed ... Anixa Biosciences Inc (NASDAQ:ANIX) 2.93 Delayed Data As of Nov 17 +0.045 / +1.56% Today’s Change 2.77 Today ||| 52-Week Range 6.45 -31.18% Year-to-Date Quote Profile …Barcus covers the Healthcare sector, focusing on stocks such as Anixa Biosciences, uniQure, and Purple Biotech. According to TipRanks , Barcus has an average return of -0.9% and a 37.50% success ...SAN JOSE, Calif., April 28, 2022 /PRNewswire/ --Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...Firm. Analyst. Chardan. Matthew Barcus, Ph.D. H.C. Wainwright & Co. Yi Chen, Ph.D. Raghuram Selvaraju, Ph.D. Anixa Biosciences, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Anixa Biosciences, Inc.'s performance made by these analysts are theirs alone and do not represent …Anixa Biosciences plunges on upsizing stock offering to $22.5M SA News Tue, Mar. 23, 2021 2 Comments. Anixa Biosciences to raise $10M in bought deal offering SA News Mon, Mar. 22, 2021 1 Comment.

SAN JOSE, Calif., Oct. 26, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...

Complete Anixa Biosciences Inc. stock information by Barron's. View real-time ANIX stock price and news, along with industry-best analysis.

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic ...View ANIXA BIOSCIENCES INC ANIX investment & stock information. Get the latest ANIXA BIOSCIENCES INC ANIX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Analyst's Opinion · Consensus Rating. Anixa Biosciences has received a consensus rating of Buy. · Price Target Upside/Downside. According to analysts' consensus ...Anixa Biosciences (NASDAQ: ANIX) is a San Jose, California-based biopharmaceutical company. The company is focused on developing therapeutics to treat cancer and infectious diseases. The pipeline ...Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock. News provided by. Anixa Biosciences, Inc. 22 Mar, 2021, 17:18 ET. SAN JOSE, Calif., March 22, 2021 /PRNewswire ...Stock analysis for Anixa Biosciences Inc (ANIX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Stock Price Forecast The 2 analysts offering 12-month price forecasts for Anixa Biosciences Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 9.00.Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may have been bought directly from the company.According to 6 analyst offering 12-month price targets in the last 3 months, Anixa Biosciences has an average price target of $11.0 with a high of $12.00 and a low of $9.00.In the previous week, Anixa Biosciences had 3 more articles in the media than Cue Biopharma. MarketBeat recorded 4 mentions for Anixa Biosciences and 1 mentions for Cue Biopharma. Anixa Biosciences' average media sentiment score of 1.87 beat Cue Biopharma's score of 0.18 indicating that Cue Biopharma is being referred to …

The Anixa Biosciences Inc. stock price fell by -0.90% on the last day (Wednesday, 29th Nov 2023) from $3.34 to $3.31.During the last trading day the stock fluctuated 5.92% from a day low at $3.20 to a day high of $3.39.The price has risen in 6 of the last 10 days and is up by 15.73% over the past 2 weeks. Volume fell on the last day …SAN JOSE, Calif., Aug. 31, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ...SAN JOSE - Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced a presentation on results of its Phase 1a breast cancer vaccine trial on April 17, 2023, at the 2023 American Association for Cancer Research (AACR) Annual Meeting.Oct 23, 2023 · About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T ... Instagram:https://instagram. how much for a 1943 steel pennyfalabella.comcltemporary motorcycle insurancemicrosoft options Jun 22, 2023 · ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. you need a budget free trialxbil etf 21 Feb 2019 ... About Anixa Biosciences, Inc. Anixa, a cancer-focused biotechnology company, is harnessing the body's immune system in the fight against cancer. cloverhealth stock Chardan Capital analyst Matthew Barcus maintained a Buy rating on Anixa Biosciences (ANIX – Research Report) today and set a price target of $9.00.The company’s shares opened today at $4.12 ...See Anixa Biosciences, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading ...The Anixa Biosciences Inc. stock price fell by -0.90% on the last day (Wednesday, 29th Nov 2023) from $3.34 to $3.31.During the last trading day the stock fluctuated 5.92% from a day low at $3.20 to a day high of $3.39.The price has risen in 6 of the last 10 days and is up by 15.73% over the past 2 weeks. Volume fell on the last day …